• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川陈皮素以生物钟依赖的方式促进白色脂肪组织的脂解。

Nobiletin promotes lipolysis of white adipose tissue in a circadian clock-dependent manner.

机构信息

Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China; Department of Toxicological and Biochemical Test, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China.

Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.

出版信息

J Nutr Biochem. 2024 Oct;132:109696. doi: 10.1016/j.jnutbio.2024.109696. Epub 2024 Aug 1.

DOI:10.1016/j.jnutbio.2024.109696
PMID:39094217
Abstract

Nobiletin has been reported to protect against obesity-related metabolic disorders by enhancing the circadian rhythm; however its effects on lipid metabolism in adipose tissue are unclear. In this study, mice were fed with high-fat diet (HFD) for four weeks firstly and gavaged with 50 or 200 mg/kg bodyweight/day nobiletin at Zeitgeber time (ZT) 4 for another four weeks while still receiving HFD. At the end of the 8-week experimental period, the mice were sacrificed at ZT4 or ZT8 on the same day. Mature 3T3-L1 adipocytes were treated with nobiletin in the presence or absence of siBmal1, siRora, siRorc, SR8278 or SR9009. Nobiletin reduced the weight of white adipose tissue (WAT) and the size of adipocytes in WAT. At ZT4, nobiletin decreased the TG, TC and LDL-c levels and increased serum FFA level and glucose tolerance. Nobiletin triggered the lipolysis of mesenteric and epididymal WAT at both ZT4 and ZT16. Nobiletin increased the level of RORγ at ZT16, that of BMAL1 and PPARγ at ZT4, and that of ATGL at both ZT4 and ZT16. Nobiletin increased lipolysis and ATGL levels in 3T3-L1 adipocytes in Bmal1- or Rora/c- dependent manner. Dual luciferase assay indicated that nobiletin enhanced the transcriptional activation of RORα/γ on Atgl promoter and decreased the repression of RORα/γ on PPARγ-binding PPRE. Promoter deletion analysis indicated that nobiletin inhibited the suppression of PPARγ-mediated Atgl transcription by RORα/γ. Taken together, nobiletin elevated lipolysis in WAT by increasing ATGL levels through activating the transcriptional activity of RORα/γ and decreasing the repression of RORα/γ on PPARγ-binding PPRE.

摘要

川陈皮素已被报道通过增强昼夜节律来预防肥胖相关的代谢紊乱;然而,其对脂肪组织中脂质代谢的影响尚不清楚。在这项研究中,首先用高脂肪饮食(HFD)喂养小鼠 4 周,然后在 Zeitgeber 时间(ZT)4 时用 50 或 200mg/kg 体重/天的川陈皮素灌胃 4 周,同时仍接受 HFD。在 8 周的实验期结束时,在同一天的 ZT4 或 ZT8 处死小鼠。成熟的 3T3-L1 脂肪细胞在存在或不存在 siBmal1、siRora、siRorc、SR8278 或 SR9009 的情况下用川陈皮素处理。川陈皮素减少白色脂肪组织(WAT)的重量和 WAT 中脂肪细胞的大小。在 ZT4 时,川陈皮素降低了 TG、TC 和 LDL-c 水平,增加了血清 FFA 水平和葡萄糖耐量。川陈皮素在 ZT4 和 ZT16 时触发肠系膜和附睾 WAT 的脂肪分解。川陈皮素在 ZT16 时增加了 RORγ 的水平,在 ZT4 时增加了 BMAL1 和 PPARγ 的水平,在 ZT4 和 ZT16 时增加了 ATGL 的水平。川陈皮素以 Bmal1-或 Rora/c-依赖的方式增加了 3T3-L1 脂肪细胞中的脂肪分解和 ATGL 水平。双荧光素酶测定表明,川陈皮素增强了 Atgl 启动子上 RORα/γ 的转录激活,并降低了 RORα/γ 对 PPARγ 结合 PPRE 的抑制作用。启动子缺失分析表明,川陈皮素抑制了 RORα/γ 对 PPARγ 介导的 Atgl 转录的抑制作用。总之,川陈皮素通过激活 RORα/γ 的转录活性和降低 RORα/γ 对 PPARγ 结合 PPRE 的抑制作用,增加 ATGL 水平,从而提高 WAT 中的脂肪分解。

相似文献

1
Nobiletin promotes lipolysis of white adipose tissue in a circadian clock-dependent manner.川陈皮素以生物钟依赖的方式促进白色脂肪组织的脂解。
J Nutr Biochem. 2024 Oct;132:109696. doi: 10.1016/j.jnutbio.2024.109696. Epub 2024 Aug 1.
2
Lipolysis and thermogenesis in adipose tissues as new potential mechanisms for metabolic benefits of dietary fiber.脂肪组织中的脂肪分解和产热作为膳食纤维代谢益处的新潜在机制。
Nutrition. 2017 Jan;33:118-124. doi: 10.1016/j.nut.2016.05.006. Epub 2016 Jun 2.
3
Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis.氟西汀通过减少脂肪甘油三酯脂肪酶介导的脂肪细胞脂解部分改善高脂肪饮食诱导的代谢异常。
Biomed Pharmacother. 2021 Sep;141:111848. doi: 10.1016/j.biopha.2021.111848. Epub 2021 Jun 28.
4
Nobiletin Stimulates Adrenal Hormones and Modulates the Circadian Clock in Mice.川陈皮素可刺激肾上腺激素并调节小鼠的生物钟。
Nutrients. 2024 May 15;16(10):1491. doi: 10.3390/nu16101491.
5
Adipose Snail1 Regulates Lipolysis and Lipid Partitioning by Suppressing Adipose Triacylglycerol Lipase Expression.脂肪蜗牛1通过抑制脂肪甘油三酯脂肪酶的表达来调节脂肪分解和脂质分配。
Cell Rep. 2016 Nov 15;17(8):2015-2027. doi: 10.1016/j.celrep.2016.10.070.
6
Excessive fat expenditure in MCT-induced heart failure rats is associated with BMAL1/REV-ERBα circadian rhythmic loop disruption.MCT 诱导心衰大鼠过度脂肪消耗与 BMAL1/REV-ERBα 昼夜节律环破坏有关。
Sci Rep. 2024 Apr 7;14(1):8128. doi: 10.1038/s41598-024-58577-8.
7
A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice.在小鼠中,β细胞的脂肪甘油三酯脂肪酶(ATGL)-脂解作用/脂肪组织轴通过胰岛素分泌来控制能量平衡和体重。
Diabetologia. 2016 Dec;59(12):2654-2663. doi: 10.1007/s00125-016-4105-2. Epub 2016 Sep 27.
8
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.过氧化物酶体增殖物激活受体γ在体外和体内均可调节脂肪细胞中的脂肪甘油三酯脂肪酶。
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1736-45. doi: 10.1152/ajpendo.00122.2007. Epub 2007 Sep 11.
9
Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes.橙皮素增强3T3-L1脂肪细胞的分化和脂肪分解。
Biochem Biophys Res Commun. 2007 Jun 1;357(2):371-6. doi: 10.1016/j.bbrc.2007.03.169. Epub 2007 Apr 5.
10
Artemisia extracts activate PPARγ, promote adipogenesis, and enhance insulin sensitivity in adipose tissue of obese mice.青蒿提取物可激活过氧化物酶体增殖物激活受体γ(PPARγ),促进脂肪生成,并增强肥胖小鼠脂肪组织中的胰岛素敏感性。
Nutrition. 2014 Jul-Aug;30(7-8 Suppl):S31-6. doi: 10.1016/j.nut.2014.02.013. Epub 2014 Mar 12.

引用本文的文献

1
Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development.非酒精性脂肪性肝病中PPARγ的治疗靶点:疗效、安全性与药物研发
Drug Des Devel Ther. 2025 Aug 22;19:7293-7319. doi: 10.2147/DDDT.S524893. eCollection 2025.